Reports
Sale
Global Zika Virus Therapeutics Market Size, Share, Forecast: By Product: Acetaminophen, Other NSAIDs; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032
Global Zika Virus Therapeutics Market Outlook
The global zika virus therapeutics market stood at a value of around USD 19.69 billion in 2023. The industry is further projected to grow at a CAGR of 5.6% over the forecast period of 2024-2032 to attain USD 32.15 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global zika virus therapeutic market is being driven by the rising demand to prevent the virus from spreading, rapid technological advancements leading to the development of vaccines to fight it, along with the increased R&D in the field of zika virus RNA treatment.
Market Segmentation
Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the product type, the industry can be segmented into:
- Acetaminophen
- Other NSAIDs
The EMR report further looks into the regional zika virus therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Market Analysis
The global zika virus therapeutics market is being supported by the growing incidences of zika virus infection, which is gradually reaching epidemic proportions throughout the world. Zika virus infection have the ability to affect both adults and foetuses in the form of different clinical manifestations such as low-grade fever combined with arthralgia, conjunctivitis, pruritic maculopapular rashes, optic neuropathy, microcephalus, and congenital glaucoma. Especially in Latin America and the Caribbean, the number of instances of zika virus infection and related comorbidities is anticipated to increase considerably, leading to the growth of zika virus therapeutics market in the region and further aiding the global industry growth. The need to prevent and treat zika-related congenital disabilities and the development of the latest vaccines to prevent the further spread of the virus is aiding the growth of the industry globally. North America is anticipated to dominate the global zika virus therapeutics market over the forecast period. Within North America, the U.S. holds the most extensive industry-sponsored clinical trials.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global zika virus therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Aurobindo Pharma Ltd.
- Johnson & Johnson Services, Inc.
- Perrigo Co. Plc
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Zika Virus Therapeutics Market Analysis
8.1 Key Industry Highlights
8.2 Global Zika Virus Therapeutics Historical Market (2018-2023)
8.3 Global Zika Virus Therapeutics Market Forecast (2024-2032)
8.4 Global Zika Virus Therapeutics Market by Product
8.4.1 Acetaminophen
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Other NSAIDs
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Zika Virus Therapeutics Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Zika Virus Therapeutics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Zika Virus Therapeutics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Zika Virus Therapeutics Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Zika Virus Therapeutics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Zika Virus Therapeutics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Company Profiles
17.2.1 Aurobindo Pharma Ltd.
17.2.1.1 Company Overview
17.2.1.2 Product Portfolio
17.2.1.3 Demographic Reach and Achievements
17.2.1.4 Certifications
17.2.2 Johnson and Johnson Services, Inc.
17.2.2.1 Company Overview
17.2.2.2 Product Portfolio
17.2.2.3 Demographic Reach and Achievements
17.2.2.4 Certifications
17.2.3 Perrigo Co. Plc
17.2.3.1 Company Overview
17.2.3.2 Product Portfolio
17.2.3.3 Demographic Reach and Achievements
17.2.3.4 Certifications
17.2.4 Sun Pharmaceutical Industries Ltd.
17.2.4.1 Company Overview
17.2.4.2 Product Portfolio
17.2.4.3 Demographic Reach and Achievements
17.2.4.4 Certifications
17.2.5 Takeda Pharmaceutical Company Limited
17.2.5.1 Company Overview
17.2.5.2 Product Portfolio
17.2.5.3 Demographic Reach and Achievements
17.2.5.4 Certifications
17.2.6 Others
18 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Zika Virus Therapeutics Market: Key Industry Highlights, 2018 and 2032
2. Global Zika Virus Therapeutics Historical Market: Breakup by Product (USD Million), 2018-2023
3. Global Zika Virus Therapeutics Market Forecast: Breakup by Product (USD Million), 2024-2032
4. Global Zika Virus Therapeutics Historical Market: Breakup by Region (USD Million), 2018-2023
5. Global Zika Virus Therapeutics Market Forecast: Breakup by Region (USD Million), 2024-2032
6. North America Zika Virus Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2023
7. North America Zika Virus Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
8. Europe Zika Virus Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2023
9. Europe Zika Virus Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Asia Pacific Zika Virus Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2023
11. Asia Pacific Zika Virus Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Latin America Zika Virus Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2023
13. Latin America Zika Virus Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Middle East and Africa Zika Virus Therapeutics Historical Market: Breakup by Country (USD Million), 2018-2023
15. Middle East and Africa Zika Virus Therapeutics Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Global Zika Virus Therapeutics Market Structure
Key Questions Answered in the Report
In 2023, the global zika virus therapeutics market attained a value of nearly USD 19.69 billion.
The market is projected to grow at a CAGR of 5.6% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 32.15 billion by 2032.
The major drivers of the market include growing incidences of zika virus infection and development of vaccines.
Increasing research and development (R&D) activities and technological advancements are the key trends propelling the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products include acetaminophen and other NSAIDs.
The major players in the market are Aurobindo Pharma Ltd., Johnson & Johnson Services, Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited, among others.
Analyst Review
The global zika virus therapeutics market attained a value of USD 19.69 billion in 2023, driven by the rising zika virus infections. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 5.6%. The market is projected to reach USD 32.15 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product types, the zika virus therapeutics industry can be segmented into acetaminophen and other NSAIDs. The major regional markets for zika virus therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America has the largest market share. The key players in the above market include Aurobindo Pharma Ltd., Johnson & Johnson Services, Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER